Jazz Pharma submits zanidatamab BLA to US FDA seeking approval for previously treated HER2-positive metastatic BTC
Pharmabiz.com,
Jazz Pharmaceuticals plc announced that the company has completed the rolling submission of a Biologics License Application (BLA…